Patient-centred care of patients with ventricular arrhythmias and risk of sudden cardiac death: What do the 2015 European Society of Cardiology guidelines add?

Abstract

Nurses and allied professionals are at the forefront of care delivery in patients with arrythmogenic risk and have a responsibility to deliver care that is focused on their individual needs. The 2015 European Society of Cardiology guideline on prevention of ventricular arrhythmia and sudden cardiac death heralds a step-change in patient and family focus and interdisciplinary involvement. This development reflects a recognition within the European Society of Cardiology that chronic care of patients with cardiovascular conditions can be improved by involving all stakeholders, making use of multidisciplinary interventions, and placing the patient at the centre of the care process. In this article, taskforce contributors discuss the latest evidence and highlight some of the most pertinent issues for nurses involved in patient-centred care of patients and families with ventricular arrhythmias and/or risk of sudden death.

Keywords

Arrhythmia guideline patient-centred

Get full access to this article

View all access options for this article.

References

Priori

Blomstrom-Lundqvist

Mazzanti

et al . 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793–2867. Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Ventricular-Arrhythmias-and-the-Prevention-of-Sudden-Cardiac-Death

Ekman

Swedberg

Taft

et al . Person-centered care – ready for prime time. Eur J Cardiovasc Nurs 2011; 10: 248–251.

Kane

Murtagh

FEM

Ryan

et al . The gap between policy and practice: A systematic review of patient-centred interventions in chronic heart failure. Heart Fail Rev 2015; 20: 673–687.

Linnarsson

Bubini

Perseius

. A meta-synthesis of qualitative research into needs and experiences of significant others to critically ill or injured patients. J Clin Nurs 2010; 19: 3102–3111.

Thoren

Danielson

Herlitz

et al . Spouses’ experiences of a cardiac arrest at home: An interview study. Eur J Cardiovasc Nurs 2010; 9: 161–167.

Holm

Norekval

Falun

et al . Partners’ ambivalence towards cardiac arrest and hypothermia treatment: A qualitative study. Nurs Crit Care 2012; 17: 231–238.

Schmidt

Azoulay

. Having a loved one in the ICU: The forgotten family. Curr Opin Crit Care 2012; 18: 540–7.

Doolittle

Sauve

. Impact of aborted sudden cardiac death on survivors and their spouses: The phenomenon of different reference points. Am J Crit Care 1995; 4: 389–396.

Schron

Exner

Yao

et al . Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589–594.

10.

Irvine

Dorian

Baker

et al . Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002; 144: 282–289.

11.

Magyar-Russell

Thombs

Cai

et al . The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. J Psychosom Res 2011; 71: 223–231.

12.

Braunschweig

Boriani

Bauer

et al . Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. Europace 2010; 12: 1673–1690.

13.

Lang

Becker

Wilke

et al . Anxiety disorders in patients with implantable cardioverter defibrillators: Frequency, course, predictors, and patients’ requests for treatment. Pacing Clin Electrophysiol 2014; 37: 35–47.

14.

Kapa

Rotondi-Trevisan

Mariano

et al . Psychopathology in patients with ICDs over time: Results of a prospective study. Pacing Clin Electrophysiol. 2010; 33: 198–208.

15.

Versteeg

Theuns

Erdman

et al . Posttraumatic stress in implantable cardioverter defibrillator patients: The role of pre-implantation distress and shocks. Int J Cardiol 2011; 146: 438–439.

16.

Morken

Isaksen

Karlsen

et al . Shock anxiety among implantable cardioverter defibrillator recipients with recent tachyarrhythmia. Pacing Clin Electrophysiol 2012; 35: 1369–1376.

17.

Pedersen

van den Broek

Erdman

et al . Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 2010; 12: 1446–1452.

18.

Mastenbroek

Versteeg

Jordaens

et al . Ventricular tachyarrhythmias and mortality in patients with an implantable cardioverter defibrillator: Impact of depression in the MIDAS cohort. Psychosom Med 2014; 76: 58–65.

19.

Dunbar

Dougherty

Sears

et al . Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: A scientific statement from the American Heart Association. Circulation 2012; 126: 2146–2172.

20.

Thylén

Dekker

Jaarsma

et al . Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res 2014; 77: 122–127.

21.

Vijgen

Botto

Camm

et al . Consensus statement of the European Heart Rhythm Association: Updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 2009; 11: 1097–1107.

22.

Steinke

Gill-Hopple

Valdez

et al . Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung 2005; 34: 299–308.

23.

Berg

Higgins

Reilly

et al . Sleep quality and sleepiness in persons with implantable cardioverter defibrillators: Outcome from a clinical randomized longitudinal trial. Pacing Clin Electrophysiol 2012; 35: 431–443.

24.

Vazquez

Kuhl

Shea

et al . Age-specific differences in women with implantable cardioverter defibrillators: An international multi center study. Pacing Clin Electrophysiol 2008; 31: 1528–1534.

25.

Zeigler

Nelms

. Almost normal: Experiences of adolescents with implantable cardioverter defibrillators. J Spec Pediatr Nurs 2009; 14: 142–151.

26.

Soumerai

McLaughlin

Spiegelman

et al . Adverse outcomes of underuse of betablockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277: 115–121.

27.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) investigators. N Engl J Med 1997; 337: 1576–1583.

28.

Moss

Zareba

Hall

et al . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883.

29.

Kong

Al-Khatib

Sanders

et al . Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis. Cardiol J 2011; 18: 503–514.

30.

Santangeli

Di Biase

Dello Russo

et al . Meta-analysis: Age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med 2010; 153: 592–599.

31.

Healey

Hallstrom

Kuck

et al . Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007; 28: 1746–1749.

32.

Chan

Nallamothu

Spertus

et al . Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009; 2: 16–24.

33.

Brullmann

Dichtl

Paoli

et al . Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged >/=75 years versus those <75 years. Am J Cardiol 2012; 109: 712–717.

34.

Al-Khatib

Hellkamp

Bardy

et al . Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA 2013; 309: 55–62.

35.

Noyes

Corona

Zwanziger

et al . Health-related quality of life consequences of implantable cardioverter defibrillators: Results from MADIT II. Med Care 2007; 45: 377–385.

36.

Lunney

Lynn

Foley

et al . Patterns of functional decline at the end of life. JAMA 2003; 289: 2387–2392.

37.

Hill

McIlfatrick

Taylor

et al . Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations. Eur J Cardiovasc Nurs 2016; 15: 20–29.

38.

Kinch Westerdahl

Sjöblom

Mattiasson

et al . Implantable cardioverter-defibrillator therapy before death: High risk for painful shocks at end of life. Circulation 2014; 129(4): 422–429.

39.

Padeletti

Arnar

Boncinelli

et al . EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010; 12: 1480–1489.

40.

Nambisan

Chao

. Dying and defibrillation: A shocking experience. Palliat Med 2004; 18: 482–483.

41.

World Health Organization (WHO). WHO definition of palliative care. Geneva: WHO, 2009. Available at: http://www.who.int/cancer/palliative/definition/en/ (accessed 22 March 2017).

42.

Kay

Bittner

. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction. Circ Arrhythm Electrophysiol 2009; 2: 336–339.

43.

Beauchamp

Childres

. Principles of biomedical ethics. 6th ed. Oxford: Oxford University Press, 2001.

44.

Lampert

Hayes

Annas

et al . HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7: 1008–1026.

45.

Marinskis

van Erven

. EHRA Scientific Initiatives Committee. Deactivation of implanted cardioverterdefibrillators at the end of life: Results of the EHRA survey. Europace 2010; 12: 1176–1177.

46.

Goldstein

Bradley

Zeidman

et al . Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: Results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol 2009; 54: 371–373.

47.

Stromberg

Fluur

Miller

et al . ICD recipients’ understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life. Pacing Clin Electrophysiol 2014; 37: 834–842.

48.

Thylen

Wenemark

Fluur

et al . Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator. Eur J Cardiovasc Nurs 2014; 13: 142–151.

49.

Jaarsma

Beattie

Ryder

et al . Palliative care in heart failure: A position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009; 11: 433–443.